James MackayCo Founder

United States - San Diego, California

Distinguished scientist and global life sciences business leader with strong record of bringing multiple drugs to market and patients

|| Strategic thinker with ability to define and implement strategic vision through clear communication and innovative operational delivery

|| Develops strategic and operational partnerships, and builds inspiring cultures via authenticity, development of mutual trust, empowerment and mentoring

|| Creates transparent and open environments allowing staff to raise concerns, cultivating deep thinking, and achieving breakthrough results

|| Experience running large pharmaceutical and small biotechnology businesses with ability to work across international boundaries and cultures, enhancing delivery through diversity

|| Value-driven decision making, the courage to make tough decisions to achieve value-added delivery to the business, and a purposefulness and drive to deliver an outcome that creates positive and lasting change

CAREER HIGHLIGHTS

• Led successful $1.2B acquisition and transition of Ardea Biosciences into AstraZeneca

• Achieved FDA and EMA approval of Zurampic, the first novel MOA for the treatment of gout
in over 50 years

• Led successful commercial licensing of Zurampic and Duzallo to Ironwood Pharmaceuticals and
Grunenthal

• Transformed the AstraZeneca/BMS Diabetes global development and commercial collaboration, and
established Onglyza, Kombiglyze XR and Komboglyze as key growth drivers in the AZ portfolio

• Designed and implemented multiple innovative delivery and partnership models including an
industry leading approach to delivery of outsourced clinical work through development of strategic
partnerships with CROs

• Designed and implemented multiple strategic re-organizations, led major global change
management, whilst delivering improved efficiencies and productivity